Moderna Wavers Despite Hard-Fought FDA Win; Will Its Sprint Restart?Investors Business Daily • 08/06/26
Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic FutureBarrons • 08/06/26
The Food and Drug Administration approved Moderna's mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February.WSJ • 08/06/26
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo EbolavirusAccesswire • 08/04/26
Moderna Reports Second Quarter 2026 Financial Results and Provides Business UpdatesAccesswire • 07/31/26
Moderna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?Zacks Investment Research • 07/29/26